Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.20.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Revenue $ 0 $ 57 $ 0 $ 121
Operating expenses:        
Research and development 8,469 8,474 18,335 18,158
Selling, general and administrative 3,357 2,779 5,966 5,021
Total operating expenses 11,826 11,253 24,301 23,179
Loss from operations (11,826) (11,196) (24,301) (23,058)
Other (income) expense:        
Loss on extinguishment of debt 806 231 806 1,045
Amortization of debt issuance costs and discount 321 373 599 573
Interest income (36) (233) (183) (513)
Interest expense 319 209 529 574
Other income (60) 0 (405) 0
Other expense 602 0 602 0
Warrant liabilities fair value adjustment (3,560) (2,049) (8,329) 4,473
Derivative liabilities fair value adjustment (693) (1,324) (1,393) 2,101
Total other (income) expense (2,301) (2,793) (7,774) 8,253
Loss before taxes (9,525) (8,403) (16,527) (31,311)
Income tax benefit (3,144) 0 (3,144) 0
Net loss $ (6,381) $ (8,403) $ (13,383) $ (31,311)
Net loss per share - basic and diluted $ (0.64) $ (1.58) $ (1.35) $ (6.10)
Weighted average common shares outstanding – basic and diluted 10,009,614 5,327,766 9,877,094 5,130,855